Which form of dopamine is the substrate for the human dopamine transporter: The cationic or the uncharged species?

Journal of Biological Chemistry

Volumn 274, Issue 8, 1999, Pages 4876-4882

  Berfield, Janet L ^a   Wang, Lijuan C ^a   Reith, Maarten E A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER;

ARTICLE; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; HUMAN; MOLECULAR RECOGNITION; PH; PRIORITY JOURNAL; PROTEIN TRANSPORT; TRANSPORT KINETICS;

EID: 0033582486     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.274.8.4876     Document Type: Article

References (51)

1. Zimanyi, I., Lajtha, A., and Reith, M. E. A. (1989) Naunyn-Schmiedeberg's Arch. Pharmacol. 340, 626-632
2. Garris, P. A., Ciolkowski, E. L., Pastore, P., and Wightman, R. M. (1994) J. Neurosci. 14, 6084-6093
3. McElvain, J. S., and Schenk, J. O. (1992) Biochem. Pharmacol. 43, 2189-2199
4. Povlock, S., and Amara, S. G. (1997) in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith, M. E. A., ed) pp. 1-28, Humana Press, Totowa, NJ
5. Rudnick, G. (1997) in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith, M. E. A., ed) pp. 73-100, Humana Press, Totowa, NJ
6. Gu, H. H., and Rudnick, G. (1996) Soc. Neurosci. Abstr. 22, 370
7. Krueger, B. K. (1990) J. Neurochem. 55, 260-267
8. Gu, H., Wall, S. C., and Rudnick, G. (1994) J. Biol. Chem. 269, 7124-7130
9. Sonders, M. S., Zhu, S. J., Zahniser, N. R., Kavanaugh, M. P., and Amara, S. G. (1997) J. Neurosci. 17, 960-974
10. Armstrong, J., and Barlow, R. B. (1976) Br. J. Pharmacol. 57, 501-516
11. Lewis, G. P. (1954) Br. J. Pharmacol. Chemother. 9, 488-493
12. Mack, F., and Bönisch, H. (1979) Naunyn-Schmiedeberg's Arch. Pharmacol. 310, 1-9
13. Rudnick, G., Kirk, K. L., Fishkes, H., and Schuldiner, S. (1989) J. Biol. Chem. 264, 14865-14868
14. Gu, H. H., Wall, S., and Rudnick, G. (1996) J. Biol. Chem. 271, 6911-6916
15. Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D. M., and Uhl, G. R. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 7782-7785
16. Edvardsen, O., and Dahl, S. G. (1994) Mol. Brain Res. 27, 265-274
17. Njus, D., Kelley, P. M., and Harnadek, G. J. (1986) Biochim. Biophys. Acta 853, 237-265
18. Darchen, F., Scherman, D., Desnos, C., and Henry, J. P. (1988) Biochem. Pharmacol. 37, 4381-4387
19. Johnson, R. G. J. (1988) Physiol. Rev. 68, 232-307
20. Eshleman, A. J., Henningsen, R. A., Neve, K. A., and Janowsky, A. (1994) Mol. Pharmacol. 45, 312-316
21. Eshleman, A. J., Stewart, E., Evenson, A. K., Mason, J. N., Blakely, R. D., Janowsky, A., and Neve, K. A. (1997) J. Neurochem. 69, 1459-1466
22. Xu. C., Coffey, L. L., and Reith, M. E. A. (1995) Biochem. Pharmacol. 49, 339-350
23. Reith, M. E., Xu, C., Zhang, L., and Coffey, L. L. (1996) Naunyn-Schmiedeberg's Arch. Pharmacol. 354, 295-304
24. Reith, M. E. A., de Costa, B., Rice, K. C., and Jacobson, A. E. (1992) Eur. J. Pharmacol. 227, 417-425
25. Maxwell, R. A., Ferris, R. M., and Burcsu, J. E. (1976) in The Mechanism of Neuronal and Extraneuronal Transport of Catecholamines (Paton, D. M., ed) pp. 95-153, Raven Press, New York
26. Masuda, M., Kanai, S., and Miyasaka, K. (1998) Am. J. Physiol. 274, G29-G34
27. Molinoff, P. B., Brimijoin, S., and Axelrod, J. (1971) Biochem. J. 123, 32P-33P
28. Kamal, L. A., Arbilla, S., Galzin, A. M., and Langer, S. Z. (1983) J. Pharmacol. Exp. Ther. 227, 446-458
29. Kammerer, R. C., Amiri, B., and Cho, A. K. (1979) J. Med. Chem. 22, 352-355
30. Steinmetz, P. R., and Balko, C. (1973) N. Engl. J. Med. 289, 141-146
31. Katzung, B. G. (1995) in Basic & Clinical Pharmacology (Katzung, B. G., ed) pp. 1-8, Appleton & Lange, Norwalk, CT
32. Collins, G. G., and West, G. B. (1968) Br. J. Pharmacol. 34, 514-522
33. Silinsky, E. M. (1974) Br. J. Pharmacol. 51, 367-371
34. Sachs, C. (1970) Acta Physiol. Scand. Suppl. 341, 1-66
35. Wu, Q., Coffey, L. L., and Reith, M. E. (1997) J. Neurochem. 69, 1106-1118
36. Courtney, K. R., and Strichartz, G. R. (1987) in Handbook of Experimental Pharmacology (Strichartz, G. R., ed) Vol. 81, pp. 53-94, Springer-Verlag, Berlin
37. DeLean, A., Munson, P. J., and Rodbard, D. (1978) Am. J. Physiol. 235, E97-E102
38. Munson, P. J., and Rodbard, D. (1980) Anal. Biochem. 107, 220-239
39. Xu, C., and Reith, M. E. (1996) J. Pharmacol. Exp. Ther. 278, 1340-1348
40. Cheng, Y., and Prusoff, W. H. (1973) Biochem. Pharmacol. 22, 3099-3108
41. Nettleton, J., and Wang, G. K. (1990) Biophys. J. 58, 95-106
42. Amejdki-Chab, N., Benmansour, S., Costentin, J., and Bonnet, J. J. (1992) J. Neurochem. 59, 1795-1804
43. Taylor, C. P., and Meldrum, B. S. (1995) Trends Pharmacol. Sci. 16, 309-316
44. Leo, A., Hansch, C., and Elkins, D. (1971) Chem. Rev. 71, 525-616
45. Hille, B. (1984) Ionic Channels of Excitable Membranes, pp. 287-289, Sinauer Associates, Inc., Sunderland, MA
46. Chen, J.-G., Sachpatzidis, A., and Rudnick, G. (1997) J. Bull. Chem. 272, 28321-28327
47. Meiergerd, S. M., and Schenk, J. O. (1994) J. Neurochem. 62, 998-1008
48. Wall, S. C., Innis, R. B., and Rudnick, G. (1993) Mol. Pharmacol. 43, 264-270
49. Bonnet, J. J., Benmansour, S., Vaugeois, J. M., and Costentin, J. (1988) J. Neurochem. 50, 759-765
50. Amejdki-Chab, N., Costentin, J., and Bonnet, J. J. (1992) J. Neurochem. 58, 793-800
51. Andersen, P. H. (1987) J. Neurochem. 48, 1887-1896